bortezomib

April 18, 2019

Velcade Add-on Doesn’t Improve Survival Outcomes in Newly Diagnosed DLBCL, Trial Shows

News

Adding Velcade (bortezomib) to standard chemotherapy is well-tolerated but does not improve the survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL), even after stratifying patients according to ... Read more

July 26, 2018

Velcade-based Therapy Effective in Certain East Asian Mantle Cell Lymphoma Patients, Study Finds

News

A treatment combination including Velcade (bortezomib) was seen to be more effective than the standard R-CHOP chemotherapy in East Asian patients with mantle cell lymphoma (MCL) who cannot undergo a stem ... Read more

February 16, 2016March 8, 2016

Negative-Data Clinical Trials in Lymphoma

To stay updated with the latest lymphoma clinical trials news, click here: http://bit.ly/1QoY2Uw Learn more about what happens after a lymphoma clinical trial ends here: http://bit.ly/1Rp5aB2

August 4, 2015August 4, 2015

Double Treatment Safe and Effective in Heavily Pretreated Non-Hodgkin’s Lymphoma Patients

News

Results from a recent phase 2 study published in the journal Cancer showed that temsirolimusin combined with bortezomib is efficient and safe in patients with heavily pretreated B-cell non-Hodgkin’s lymphoma. “For many ... Read more